VAL to use proprietary AI and recombinant technologies to fight Covid-19
Vertebrate Antibodies will utilise its proprietary AI and recombinant technologies to tackle Covid-19Vertebrate Antibodies Ltd (VAL) is joining forces with leading scientists and clinicians from University of Aberdeen and NHS Grampian.Existing tests can be unreliable and are not suited to rapid and mass deployment. This project, funded by [...]